Covering the current state of equity markets, COVID-19 outlook and portfolio positioning (5mins).
DigitalX is a technology company specialising in blockchain application development and digital asset management services. Its products allow consumers to make secure and cost-effective money transfers worldwide.
Blockchain is revolutionizing the way organisations deliver cost and time savings, by creating new markets and operating models with meaningful commercial optimisations. Blockchain is a unique data storage method. It provides a single source of truth without the need for a central intermediary, a tamper proof audit trail and the ability to securely share data with all participants in a network. DigitalX are early pioneers in the Australian blockchain industry.
Galan Lithium Limited is an ASX listed (ASX: GLN) mineral exploration company with rights and rights to earn a 100% interest in lithium brine projects located within the South American Lithium Triangle in Argentina.
The six projects, covering around 25,000 hectares, lie on the Hombre Muerto salar, one of the most important and prolific salt flats in Argentina and indeed the world. The Hombre Muerto salar is home to Livent Corporation’s El Fenix lithium brine operation, Galaxy Resources Limited’s (Galaxy) and POSCO’s Sal de Vida project and boasts the highest lithium brine grades along with the lowest impurities within Argentina.
Actinogen Medical is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes.
Our management team and scientific advisory board includes world-renowned Alzheimer’s disease and dementia researchers, and industry specialists in drug design and clinical trial management. Actinogen Medical’s drug candidate Xanamem has been specifically designed to block the production of cortisol in the brain. Drugs that reduce cortisol in the brain offer a promising new approach to slowing, or even preventing, the cognitive decline associated with Alzheimer’s disease.
More to come ...